EyePoint Pharmaceuticals Inc.

4.60
-0.39 (-7.82%)
At close: Apr 04, 2025, 3:59 PM
4.65
1.01%
After-hours: Apr 04, 2025, 05:57 PM EDT

EyePoint Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018
License And Collaboration Agreement Revenue 9.56M 7.78M 14.14M 3.6M 34K 202K 7.27M 7.42M 4.61M 11.19M 8.59M 4.17M 3.03M 6.68M 5.76M 3.71M 4.74M 55K 6.71M 543K 430K
License And Collaboration Agreement Revenue Growth +22.86%-44.95%+293.02%+10479.41%-83.17%-97.22%-1.99%+60.94%-58.78%+30.26%+106.12%+37.54%-54.66%+16.01%+55.37%-21.86%+8523.64%-99.18%+1134.81%+26.28%n/a
Product Revenue 664K 1.07M 816K 5.27M 7.39M 474K n/a n/a n/a 5.83M 3.93M 8.74M n/a 3.96M 3.47M 2.88M n/a n/a 6.71M n/a n/a
Product Revenue Growth -37.83%+30.88%-84.52%-28.69%+1459.92%n/an/an/an/a+48.55%-55.05%n/an/a+14.20%+20.39%n/an/an/an/an/an/a
Royalty Revenue 299K 627K 249K 235K 255K 9.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue Growth -52.31%+151.81%+5.96%-7.84%-97.17%n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a
Y U T I Q Product Revenue 700K 1.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Y U T I Q Product Revenue Growth -36.36%n/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/an/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Jun 30, 2018Jun 30, 2017Jun 30, 2016Jun 30, 2015
China Revenue 823K 851K 11.71M 1.12M 2.86M 7.44M 1.52M 26.46M
China Revenue Growth -3.29%-92.73%+944.87%-60.82%-61.54%+389.41%-94.26%n/a
United States Revenue 40.48M 35.99M 22.62M 19.14M n/a n/a n/a n/a
United States Revenue Growth +12.48%+59.07%+18.18%n/an/an/an/an/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 12.99M 12.8M 14.11M 11.43M 11.04M 14.34M 14.98M 14.41M 15.23M 15.44M 15.24M 17.03M 13.43M 11.84M 10.77M 11.59M 11.06M 10.88M 12.48M 11.55M 12.14M 12.1M 11.92M 9.27M 7.81M 5.73M 2.28M 2.47M 2.57M 2.62M 2.43M 2.9M 3.29M 2.66M 2.35M 2.04M 1.97M 2.41M 2.04M
Selling, General, and Administrative Revenue Growth +1.52%-9.26%+23.39%+3.61%-23.07%-4.24%+3.94%-5.37%-1.37%+1.31%-10.49%+26.75%+13.43%+9.92%-7.02%+4.72%+1.69%-12.85%+8.11%-4.90%+0.36%+1.49%+28.63%+18.71%+36.20%+151.29%-7.73%-3.89%-1.98%+8.16%-16.34%-11.72%+23.68%+13.21%+14.83%+3.81%-18.37%+18.13%n/a
Research and Development Revenue 29.54M 29.82M 30.14M 17.95M 17.36M 15.73M 13.62M 15.54M 11.16M 12.99M 9.95M 8.92M 8.5M 5.61M 5.48M 5.21M 4.09M 3.28M 4.85M 4.13M 3.48M 3.96M 3.8M 4.18M 6.23M 4.76M 3.33M 4.27M 3.82M 4.21M 3.32M 3.17M 4.18M 4.1M 3.07M 3.72M 3.48M 3.2M 3.34M
Research and Development Revenue Growth -0.94%-1.05%+67.90%+3.39%+10.38%+15.51%-12.38%+39.25%-14.09%+30.64%+11.52%+4.94%+51.61%+2.30%+5.26%+27.26%+24.85%-32.50%+17.45%+18.60%-11.91%+4.16%-9.14%-32.95%+30.81%+43.31%-22.11%+11.78%-9.35%+26.74%+5.02%-24.25%+1.80%+33.51%-17.39%+6.86%+8.88%-4.22%n/a
Sales and Marketing Revenue 24K 50K 6K 185K 479K 5.29M 5.74M 5.92M 6.02M 6.88M 6.69M 7.81M 7.37M 6.66M 5.66M 5.81M 5.27M 6.09M 8.13M 7.4M 7.78M 7.28M 7.31M 4.53M 3.65M 1.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -52.00%+733.33%-96.76%-61.38%-90.94%-7.83%-3.01%-1.68%-12.60%+2.84%-14.31%+5.93%+10.74%+17.67%-2.60%+10.27%-13.47%-25.06%+9.81%-4.87%+6.78%-0.37%+61.46%+24.19%+141.14%n/an/an/an/an/an/an/an/an/an/an/an/an/an/a